DIM
EW icon

DC Investments Management’s Edwards Lifesciences EW Stock Holding History

DC Investments Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,888
Closed -$269K – 144
2020
Q2 		$269K Buy
+3,888
New +$276K 0.1% 254
2018
Q1 		– Sell
-6,627
Closed -$249K – 278
2017
Q4 		$249K Buy
+6,627
New +$243K 0.1% 257

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DC Investments Management's EW Position: Q3 2020 in Review

DC Investments Management sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 3,888 shares — an estimated $269K sold.

DC Investments Management first reported a position in EW in Q4 2017 and held it in 2 quarters. The position peaked at $269K in Q2 2020. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • DC Investments Management reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 3,888 Edwards Lifesciences shares in Q3 2020, an estimated $269K.
  • DC Investments Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 2 quarters.
  • DC Investments Management's Edwards Lifesciences position peaked at $269K in Q2 2020.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.